Café des sciences in Chicago : Human Microbiome

, Lire cette page en français , Share

Chicago (IL). January 25, 2018. Café des Sciences: The Human Microbiome with guest speaker Daniel van der Lelie, co-founder of Gusto Global. Presented by the Office for Science & Technology. Free - Open to all.

1st Café des Sciences in Chicago on the human microbiome with Dr. Daniel van der Lelie

- When : Thursday, January 25, 2018 at 6:00pm
- Where: Consulate General of France in Chicago, 205 North Michigan Avenue, Chicago, IL 60601
- Presentation and discussions in English
- Free and open to the public
- Registration required :


- 6:00pm - 6:30pm: Welcoming
- 6:30pm - 7:00pm: Presentation
- 7:00pm - 7:15pm: Q&A
- 7:15pm - 8:00pm: Networking & Light refreshments

Logistics : In order to pass security, bring valid and acceptable ID, if the name on your ID does not exactly match the name on your registration (excluding accents), you will not be permitted to access the building. Large bags are not allowed. For more information:


The role of Human microbiome by Giulia Enders in her book “Gut” explains how microbes digest our food, but also how they interfere with our health. Thus, today we tend to take care of our microbiome by being more careful about our food. The gut microbiome has become a kind of star and is now famous for its importance among the general public. However, apart from its essential role in digestion, new functions of the human microbiome are being currently discovered. Among them, modulation of the human immune response reveals novel possibilities to treat numerous human diseases including immune dysregulation, chronic infections and cancer. Exploring the diversity of the human microbiomes has recently led to the development of therapeutic approaches that are going to be presented in this talk. Indeed, numerous companies are active in this area, some developing therapeutic fecal microbiome transplants. For its part, the company Gusto Global is exploring the possibility of treating immune dysregulation, chronic intestinal infections, sepsis and various forms of food allergies using selected consortia.


Daniel van der Lelie obtained his Ph.D. in Mathematics and Sciences (specialty Molecular Genetics and Microbiology) from the University of Groningen, The Netherlands, in 1989. After a post doc at the Transgene (France), he spent 11 years at the Belgium Nuclear Research Centre (SCK) and the Flemish Institute for Technological Research (VITO), Belgium. He was further employed by the Department of Biology at Brookhaven National Laboratory, in New York, where he founded the microbiology group. He then joined the Research Triangle Institute (RTI), a nonprofit research organization, where he founded the Center for Agricultural and Environmental Biotechnology (CAEB) that was soon acquired by FMC Corporation. Further Dr. van der Lelie has been very successful as an entrepreneur. In 2015, he became one of the co-founders of Gusto Global, with Dr. S. Taghavi, Jack Gilbert (Head of the Microbiome Center at the University of Chicago), and Chris Henry (Computational Biologist at Argonne National Laboratory), a company that aims to develop microbiome-based therapeutics for immune modulation. Daniel van der Lelie is the author of over 100 papers and book chapters as well as over 20 patents. He will be soon talking at the Microbiome Drug Development Summit being held in Paris this January and will be presenting an “avant premiere” of his lattest results.

More about Dr. van der Lelie career is available here: